Global Pain Management Devices Market 2021
The global pain management devices market in terms of revenue is set to grow by US$ 2 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 6.3% during the forecast period, according to data and analytics company StrategyHelix. Rise in prevalence of chronic pain, surge in demand for long-term pain management devices, increase in average income, and availability of technologically advanced devices coupled with rise in adoption of these devices are the key factors driving market growth.
The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for pain management devices. The global pain management devices market is segmented on the basis of type, application, region. By type, it is categorized into neuromodulation & neurostimulation devices, analgesic infusion pumps, and ablation devices. The neuromodulation & neurostimulation devices segment held the largest market share in 2020. By application, the pain management devices market is divided into neuropathic pain, cancer pain, facial & migraine pain, musculoskeletal pain, and others. The neuropathic pain segment accounted for the largest market share in 2020. Based on region, the pain management devices market is divided into North America, Asia Pacific, Europe, and Rest of the World (ROW).
The report has profiled some of the key players of the market such as Abbott Laboratories Ltd., B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Boston Scientific Corporation, Johnson & Johnson, Medtronic plc, Pfizer Inc. (Hospira Inc.), Smiths Group plc, Stryker Corporation.
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the pain management devices market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Report Scope
Type: neuromodulation & neurostimulation devices, analgesic infusion pumps, and ablation devices
Application: neuropathic pain, cancer pain, facial & migraine pain, musculoskeletal pain, and others
Region: North America, Asia Pacific, Europe, and Rest of the World (ROW)
Years Considered: this report covers the period 2017 to 2027
Key Benefits for Stakeholders
Get a comprehensive picture of the global pain management devices market
Pinpoint growth sectors and trends for investment
Understand what the future of the global pain management devices market looks like
Identify the competitive landscape and window of opportunity
The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for pain management devices. The global pain management devices market is segmented on the basis of type, application, region. By type, it is categorized into neuromodulation & neurostimulation devices, analgesic infusion pumps, and ablation devices. The neuromodulation & neurostimulation devices segment held the largest market share in 2020. By application, the pain management devices market is divided into neuropathic pain, cancer pain, facial & migraine pain, musculoskeletal pain, and others. The neuropathic pain segment accounted for the largest market share in 2020. Based on region, the pain management devices market is divided into North America, Asia Pacific, Europe, and Rest of the World (ROW).
The report has profiled some of the key players of the market such as Abbott Laboratories Ltd., B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Boston Scientific Corporation, Johnson & Johnson, Medtronic plc, Pfizer Inc. (Hospira Inc.), Smiths Group plc, Stryker Corporation.
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the pain management devices market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Report Scope
Type: neuromodulation & neurostimulation devices, analgesic infusion pumps, and ablation devices
Application: neuropathic pain, cancer pain, facial & migraine pain, musculoskeletal pain, and others
Region: North America, Asia Pacific, Europe, and Rest of the World (ROW)
Years Considered: this report covers the period 2017 to 2027
Key Benefits for Stakeholders
Get a comprehensive picture of the global pain management devices market
Pinpoint growth sectors and trends for investment
Understand what the future of the global pain management devices market looks like
Identify the competitive landscape and window of opportunity
1. MARKET DEFINITION
2. RESEARCH METHODOLOGY
3. MARKET DATA & OUTLOOK
3.1 Market Value
3.2 Market Value Forecast
4. PAIN MANAGEMENT DEVICES MARKET BY TYPE
4.1 Neuromodulation & Neurostimulation Devices
4.2 Analgesic Infusion Pumps
4.3 Ablation Devices
5. PAIN MANAGEMENT DEVICES MARKET BY APPLICATION
5.1 Neuropathic Pain
5.2 Cancer Pain
5.3 Facial & Migraine Pain
5.4 Musculoskeletal Pain
5.5 Others
6. PAIN MANAGEMENT DEVICES MARKET BY REGION
6.1 North America
6.2 Asia Pacific
6.3 Europe
6.4 Rest Of The World (Row)
7. COMPANY PROFILES
7.1 Abbott Laboratories Ltd.
7.2 B. Braun Melsungen AG
7.3 Baxter International Inc.
7.4 Becton, Dickinson and Company
7.5 Boston Scientific Corporation
7.6 Johnson & Johnson
7.7 Medtronic plc
7.8 Pfizer Inc. (Hospira, Inc.)
7.9 Smiths Group plc
7.10 Stryker Corporation
8. APPENDIX
8.1 About StrategyHelix
8.2 Disclaimer
2. RESEARCH METHODOLOGY
3. MARKET DATA & OUTLOOK
3.1 Market Value
3.2 Market Value Forecast
4. PAIN MANAGEMENT DEVICES MARKET BY TYPE
4.1 Neuromodulation & Neurostimulation Devices
4.2 Analgesic Infusion Pumps
4.3 Ablation Devices
5. PAIN MANAGEMENT DEVICES MARKET BY APPLICATION
5.1 Neuropathic Pain
5.2 Cancer Pain
5.3 Facial & Migraine Pain
5.4 Musculoskeletal Pain
5.5 Others
6. PAIN MANAGEMENT DEVICES MARKET BY REGION
6.1 North America
6.2 Asia Pacific
6.3 Europe
6.4 Rest Of The World (Row)
7. COMPANY PROFILES
7.1 Abbott Laboratories Ltd.
7.2 B. Braun Melsungen AG
7.3 Baxter International Inc.
7.4 Becton, Dickinson and Company
7.5 Boston Scientific Corporation
7.6 Johnson & Johnson
7.7 Medtronic plc
7.8 Pfizer Inc. (Hospira, Inc.)
7.9 Smiths Group plc
7.10 Stryker Corporation
8. APPENDIX
8.1 About StrategyHelix
8.2 Disclaimer
